Top Markets
Coin of the day
Valeo Pharma Inc. Valeo Pharma Inc.

Valeo Pharma Inc.

VPHIF
株式のランク #41805
Valeo Pharma Inc. is a Canadian specialty pharmaceutical firm dedicated to... Valeo Pharma Inc. is a Canadian specialty pharmaceutical firm dedicated to sourcing, licensing, and selling a variety of medicinal products, with a primary emphasis on respiratory, specialized, and hospital-grade generic drugs. Its extensive product lineup features prominent asthma medications like Enerzair Breezhaler (a triple-combination LABA/LAMA/ICS) and Atectura Breezhaler (a dual-combination LABA/ICS). The company also offers Redesca, crucial for preventing and treating deep vein thrombosis and pulmonary embolism. For neurological conditions, Valeo markets Onstryv, an add-on treatment for Idiopathic Parkinson's Disease in patients on stable Levodopa, and Benztropine, an anticholinergic for PD. Pain management is addressed with M-Eslon, an extended-release morphine sulfate, while Yondelis targets soft tissue sarcoma. Beyond these, the portfolio includes Hesperco, an immune-supporting bioflavonoid antioxidant; Ametop, a skin anesthetic used before venous procedures; Ethacrynate Sodium, a loop diuretic for high blood pressure and swelling; and Amikacin, an injectable antibiotic. Founded in 2003, Valeo Pharma Inc. is headquartered in Kirkland, Canada.
株価
$0.0001
最終同期: 2026-08-11
時価総額
$9.87K
変化(1日)
0.00%
変化(1年)
-99.79%
CA
取引 Valeo Pharma Inc. (VPHIF)

カテゴリー

Valeo Pharma Inc.(VPHIF)の株価履歴
終値の最高値: $0.00 (2026-08-01)

終値の最安値: $0.85 (2020-09-01)
Valeo Pharma Inc. の株価履歴(2020 ~ 2026)
年間株価パフォーマンス
パフォーマンス
2026 (TTM) 0.00%
2025 -99.79%
2024 -64.24%
2023 -71.62%
2022 -18.52%
2021 -36.53%
2020 0.00%
類似企業または競合の株価
企業 株価 変化率 1年%
$171.67 -
DE
$166.06 27.73%
DE
$36.27 22.59%
JP
$227.14 40.04%
CH
$21.35 13.86%
IN